Kerry Rogers
Clinical trials sponsored by Kerry Rogers, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail aims to crush resistant leukemia Results expected Dec 2026 (estimated)
-
Can a Two-Drug combo wipe out hidden leukemia cells?
Disease control Recruiting nowThis phase 2 trial is testing whether combining venetoclax and zanubrutinib can drive chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) into deep remission. The study enrolls adults who either have not been treated before or whose cancer returned at least two…
Phase 2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug cocktail aims to crush resistant leukemia
Disease control Recruiting nowThis phase 2 trial tests whether combining pirtobrutinib and venetoclax can eliminate signs of cancer in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has stopped responding to standard BTK inhibitors. About 30 adults currently taking i…
Phase 2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC